The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) Strategic alternatives process underway to maximize value creation across ...

A hypoallergenic therapeutic vaccine candidate for peanut allergy was safe and tolerable, according to a poster presented at ...

Florida Democrats launched statewide town halls as part of a coordinated effort by the Democratic Party to host "People's Town Halls" in all 50 states. Florida Democratic Party Chair Nikki Fried ...

According to The London Economics, the last few weeks have seen the streets of London filled with posters that have been calling out Elon Musk. The billboards, which have been placed on Tube stations, ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced an upcoming poster for bezuclastinib at ...

SAN DIEGO — Several studies presented here at the American Academy of Allergy, Asthma, & Immunology (AAAAI)/World Allergy Organization 2025 Annual Meeting solidify the case that race-neutral ...

Antibiotics given during infancy produce changes in the microbiome that may raise the risk for childhood asthma by 30%, suggested two posters presented on February 28 at the American Academy of ...

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.

- CDX-622 inhibits SCF and TSLP-dependent inflammatory signatures in human skin - - Phase 1 study in healthy volunteers ongoing - HAMPTON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- Celldex ...

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to laryngeal hereditary ...